| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT06577194 Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in… |
date change Primary completion pushed: 2026-01-15 -> 2026-06-10 |
| 2026-08-02 | NCT06508684 Current Status of BTKi Treatment for CLL/SLL in China |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06504017 FUS-TB VS COG-TB in Small Lesions of Prostate Cancer |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT06503211 On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06479460 Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive… |
overall status: Recruiting → Unknown |
| 2026-07-29 | NCT06674187 Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and… |
Recruitment opened |
| 2026-07-29 | NCT06674187 Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and… |
date change Primary completion pushed: 2025-10-01 -> 2027-12-31 |
| 2026-07-29 | NCT06674187 Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and… |
date change Completion pushed: 2026-01-01 -> 2027-12-31 |
| 2026-07-29 | NCT04098471 Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for… |
Recruitment opened |
| 2026-07-29 | NCT04098471 Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for… |
Primary endpoint(s) modified |
| 2026-07-29 | NCT04098471 Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for… |
Enrollment reduced: 300 -> 168 participants |
| 2026-07-29 | NCT04098471 Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for… |
Trial arms changed: 3 -> 2 |
| 2026-07-29 | NCT04098471 Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for… |
date change Primary completion pushed: 2026-12 -> 2027-06-01 |
| 2026-07-29 | NCT04098471 Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for… |
date change Completion pushed: 2026-12 -> 2030-06-01 |
| 2026-07-25 | NCT06577194 Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in… |
overall status: Recruiting → Active, Not Recruiting |
| 2026-07-25 | NCT06577194 Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in… |
Primary endpoint(s) modified |
| 2026-07-25 | NCT06577194 Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in… |
date change Primary completion moved earlier: 2026-08-30 -> 2026-01-15 |
| 2026-07-25 | NCT06577194 Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in… |
date change Completion pushed: 2028-10-31 -> 2029-01-15 |
| 2026-07-22 | NCT07606820 Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea |
overall status: Enrolling by Invitation → Completed |
| 2026-07-22 | NCT07606820 Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea |
Enrollment reduced: 60 -> 30 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07763938 CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of… | Phase 1 | Not Yet Recruiting |
| 2026-08-05 | NCT07746245 The Efficacy of CAPCT in Patients With PTCL | Phase 2 | Not Yet Recruiting |
| 2026-07-28 | NCT07731828 Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum… | Phase 2 | Recruiting |
| 2026-07-28 | NCT07731841 Transcranial Magnetic Stimulation for Freezing of Gait in Parkinson's Disease | Completed | |
| 2026-07-22 | NCT07718490 Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced… | Phase 2 | Recruiting |
| 2026-07-22 | NCT07719556 Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With… | Phase 2 | Recruiting |
| 2026-07-21 | NCT07716111 Neoadjuvant SHR-A1811 and SHR-A1701 ± Pertuzumab for Potentially Immunotherapy-Sensitive… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05461820 | Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease | Graves Disease | Recruiting |
| NCT06461377 | The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy | Type 2 Diabetes | Recruiting |
| NCT05410925 | Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation… | ST Elevation Myocardial Infarction | Recruiting |
| NCT06929962 | VA Dual Sequential Therapy | Helicobacter Pylori Infection | Recruiting |
| NCT07232095 | 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy | Helicobacter Pylori | Recruiting |
| NCT07558863 | Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes | Type 2 Diabetes | Recruiting |
| NCT06532682 | Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes | Diabetic Kidney Disease | Active, Not Recruiting |
| NCT06779318 | Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected… | Pancreatic Cancer | Not Yet Recruiting |
| NCT07589699 | Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP | Breast Cancer | Not Yet Recruiting |
| NCT07377981 | Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine… | Dexmedetomidine | Not Yet Recruiting |
| Phase 3 | |||
| NCT05931263 | A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for… | Newly Diagnosed Peripheral T-cell Lymphoma | Recruiting |
| NCT05956639 | Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in… | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Recruiting |
| NCT05983783 | Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide… | Metastatic Prostate Cancer | Recruiting |
| NCT06177015 | Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC | Metastatic Prostate Cancer | Recruiting |
| NCT06350825 | Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC… | Metastatic Prostate Cancer | Recruiting |
| NCT06563869 | Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT05613478 | Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of… | Hepatocellular Carcinoma | Recruiting |
| NCT06759636 | A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared… | CTIT: Cancer Therapy Induced Thrombocytopenia | Recruiting |
| NCT06953739 | A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage… | NK-T-Cell Lymphoma, Extranodal | Not Yet Recruiting |
| NCT06895460 | A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With… | Bronchial Asthma | Not Yet Recruiting |
| NCT06939439 | Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer | Gastric Cancer Stage III | Active, Not Recruiting |
| NCT07331454 | Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer | Gastric Cancer (GC) | Not Yet Recruiting |
| NCT07668323 | Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion | Medium Vessel Occlusion | Not Yet Recruiting |
| Phase 2 | |||
| NCT05817955 | Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk… | MDS/MPN | Recruiting |
| NCT05834764 | Pyrotinib in Women With High-risk in Early Stage Breast Cancer | HER2-positive Breast Cancer | Recruiting |